Stop looking for answers,
innovate with the right partner

Novel technologies, great startups and innovative business opportunities at one click. Meet brilliant experts worldwide.

Popular on Innoget

PepsiCo

Seeking Recycling technologies for biodegradable films

  • Read
  • Posted by PepsiCo
  • ·
  • Deadline : 2024-06-11

We are looking for solutions to convert bio-based packaging back to starting materials or other high-value added chemicals (no fuels).

PepsiCo

Seeking natural colors for foods and beverages

  • Read
  • Posted by PepsiCo
  • ·
  • Project Size : 50,000 - 250,000 €

PepsiCo is evaluating different natural color ingredients and technologies to replace Yellow #5, Yellow #6, Red #40, and Blue #1 for multiple food and beverage brands in order to address consumer demand. Specific challenges are in the Red #40 (food) and Blue #1 (food & beverage) replacers.

The Procter & Gamble Company

Seeking existing market solutions targeted towards crawling insects

  • Read
  • Posted by The Procter & Gamble Company
  • ·
  • Project Size : Strategic project backed by large scale funding €

The issue of crawling insects in homes has been an ongoing issue. The popular types of crawling insects causing problems have been ants and cockroaches. The search will focus on existing market solutions targeted towards crawling insects such as ants and cockroaches (other types of crawling insects are in scope i.e., bed bugs).

Larisa Sheloukhova from Kyoto University

NanoMEDIC gene editing delivery system

  • Read
  • Posted by Larisa Sheloukhova from Kyoto University
  • ·
  • Innovative Products and Technologies

Background Gene therapy holds great potential for the treatment of genetic diseases. However, delivery to specific tissues is still a major bottleneck. Although AAV-delivered CRISPR-Cas9 editing is being developed for multiple diseases, its therapeutic translation is hindered by the limited packaging capacity of viral particles and possible immune response to them. Moreover, AAV transgenes tend to be expressed for an extended period of time, which increases off-target mutagenesis risk. Extracellular vesicles (EV) is another option and, when combined with ribonucleoprotein (RNP) delivery of CRISPR-Cas9, reduces off-target effects. The structural polyprotein Gag is typically used to package cargo into EVs, which nevertheless limits the EV packaging capacity. The present invention is an all-in-one EV delivery system termed NanoMEDIC (nanomembrane-derived extracellular vesicles for the delivery of macromolecular cargo). It is a transient EV-based CRISPR-Cas9 editing delivery system which ensures efficient genome editing in various cell types.

Universidad de Alcalá-OTRI

System for improving accessibility in learning platforms by using push buttons, for people with motor disabilities.

  • Read
  • Posted by Universidad de Alcalá-OTRI
  • ·
  • Patents for licensing

Researchers from the Automation Department of the University of Alcalá present a system that improves the accessibility to learning platforms, through an automatic or manual scanning controlled by push buttons, very useful in the education sector, specifically for people with motor disabilities. The researchers are looking for companies in electronic engineering, telecommunications, audiovisual technology and computing, companies that develop learning platforms, companies that develop computer peripherals and adapted devices, academies or training centers, interested in reaching collaboration agreements, licensing agreements or commercial agreements with technical assistance.

Jeremie Langlet from Luxembourg Institute of Health

Circular RNA biomarkers for heart failure diagnostics

  • Read
  • Posted by Jeremie Langlet from Luxembourg Institute of Health
  • ·
  • Patents for licensing

Circular RNAs are a class of noncoding RNAs covalently closed by a back spicing event, making them protected from degradation by exonuclease. They are tissue- and disease-specific and are detectable in the blood. These properties confer circRNAs with valuable potential as disease biomarkers for diagnostic and therapeutic purposes. The Cardiovascular Research team of the Luxembourg Institute of Health leaded by Dr Yvan Devaux has discovered and patented hundreds of circRNAs detectable in the blood and associated with cardiovascular conditions such as heart failure. Heart failure affects more than half of the population over 65 and represents an enormous financial burden to the society. Circular RNAs can be measured in a highly specific manner using sequencing, methods based on probe hybridization, or quantitative PCR with divergent primers. They have potential to be used in diagnostics tests, companion diagnostics or, being involved in disease development and progression, as therapeutic targets.

Job opportunities

Introducing Innoget Jobs

Great innovation projects are built with
talented and creative people.

Reach your candidate

Trusted at organizations large and small
Innoget is the most advanced innovation network to connect with decision makers interested in investing in you. It's free.

Free to join - no credit card required

How Innoget works

A trusted innovation network that will drive your project forward

Accelerate your innovation projects with a leading-edge innovation network that will put you in front of potential partners worldwide.

Read tailored updates

Read tailored updates

Find publications and meet experts to advance your projects. Follow and contact them in a leading-edge innovation network with experts from 180+ countries in all innovation disciplines.

Get in-depth stats

Get in-depth stats

See real-time stats on your innovation network activity. Build trust. Become a global innovation influencer.

Create exposure

Create exposure

Publish your posts to search for innovative solutions, present your novel technology, bring your startup to the innovation scene, publish your research outcome and much more.

Meet brilliant experts

Meet brilliant experts

Collaborate and chat with key innovation stakeholders in all business, technology and research areas.

USABLE. SECURE. GLOBAL.

Get ready to find the right partner in 30"

Invest 30" to start building your innovation network, get business opportunities, meet global partners and fast-track your innovation projects.

10"

Sign up. It's free.

Sign in and complete your professional profile to match you with the right publications, partners and opportunities.

20"

Meet brilliant partners

Novel technologies, great startups and innovative business opportunities at one click. Meet brilliant experts worldwide.

30"

Connect and chat

Find colleagues connected to your innovation and research areas. Chat, follow them and build your innovation network.

This might help you

Frequently Asked Questions

Some queries you might have before joining Innoget, the trusted innovation network.

Is Innoget free to join?

Yes. You can sign up completely free with a free Basic account. No credit card required.

Can I operate on Innoget for free?

Yes, you can.

Have more questions? Drop us an email. One of our success managers will be back to you soon.

How many publications can I post?

You can publish unlimited publications for free.

Can I manage my privacy?

Yes. You can hide or unhide your profile and allow or prevent people from following you.